Evaluation of a Multi-Purpose Solution

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

See also
Status	Clinical Trial	Phase
Completed	`NCT00789529` - Objective Testing of Tear Film Stability	N/A
Completed	`NCT03632083` - A Range of Contact Lenses and Care System Combinations	N/A
Completed	`NCT00636363` - Safety and Efficacy of a Bausch & Lomb Multipurpose Solution When Compared to Ciba Vision Aquify Multipurpose Solution	N/A
Completed	`NCT01791517` - Clinical and Laboratory Evaluation of 3 Contact Lenses With 4 Contact Lens Solutions	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT00789529 - Objective Testing of Tear Film Stability

N/A

Completed

NCT03632083 - A Range of Contact Lenses and Care System Combinations

N/A

Completed

NCT00636363 - Safety and Efficacy of a Bausch & Lomb Multipurpose Solution When Compared to Ciba Vision Aquify Multipurpose Solution

N/A

Completed

NCT01791517 - Clinical and Laboratory Evaluation of 3 Contact Lenses With 4 Contact Lens Solutions

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00710879
Study type	Interventional
Source	Bausch & Lomb Incorporated
Contact
Status	Completed
Phase	N/A
Start date	July 2008
Completion date	February 2009

Evaluation of a Multi-Purpose Solution

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms